Advances in blood-based protein biomarkers for Alzheimer's disease

Alzheimer's disease (AD) is a neurodegenerative disorder that accounts for the majority of dementia cases. While research over the past decades has made advances into understanding disease pathology, definite AD diagnosis currently relies on confirmation by autopsy. The anticipated dramatic ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Lorraine Fuhrmann, Kodadek, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706757/
https://www.ncbi.nlm.nih.gov/pubmed/23659521
http://dx.doi.org/10.1186/alzrt172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706757/
https://www.ncbi.nlm.nih.gov/pubmed/23659521
http://dx.doi.org/10.1186/alzrt172

Ejemplares similares